All stocks / BDPT
BIOADAPTIVES, INC. BDPT
Bioadaptives (BDPT): shares outstanding up 1763% in a year, convertible notes mentioned in an 8-K in November 2026, a late 10-Q notice in August 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- BIOADAPTIVES INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 16
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $18,278
- Net loss
- ($1,557,898)
It spends more than it earns
Under strainCustomers paid it $18,278 in the year. It lost $1.6 million. For every $1 that came in, about $86.23 went out.
- Cash and cash equivalents
- $215,205
- Net cash used in operating activities
- ($516,025)
The cash could run out soon
Under strainIt had $215,205 in the bank and used about $43,002 a month. At that pace the money lasts about 5 months unless it borrows or sells more shares.
- Total assets
- $225,901
- Total liabilities
- $2,355,957
It owes more than it owns
Under strainEverything the company owns adds up to $225,901. Its debts and unpaid bills add up to $2.4 million. That is about $10.43 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Shares outstanding rose from 12,008,659 (2025-10-17) to 223,677,511 (2026-11-06), up 1763%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 223,677,511 shares as of 2026-11-06: 223,677,511 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
8-K filed 2026-11-04 mentions: convertible note, equity line.
Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record
Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-K on 2026-03-31: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about BDPT
Does BDPT file reports with the SEC?
Yes. Bioadaptives files with the SEC under company number 0001575142. The most recent filing we hold is a 10-Q dated 2026-11-16.
Source recordHow many BDPT shares are outstanding?
223,677,511 shares as of 2026-11-06, as reported to the SEC. That is up 1763% from 12,008,659 on 2025-10-17.
Source recordHas BDPT filed reports late?
Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-08-14. A notice means a report was not ready on time; check whether the report followed.
Source recordIs Bioadaptives making money?
Customers paid it $18,278 in the year. It lost $1.6 million. For every $1 that came in, about $86.23 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record